Dr. Muhammad Furqan, MD

  • Oklahoma City, OK
  • Medical oncologist
NPI1306090220PAC ID3678796281
Medicare services, 2024
718
Medicare patients, 2024
234
Part D claims, 2024
1,267
Publications
77
Clinical trials
10
Practice address
1200 Childrens Ave, Oklahoma City, OK 73104
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Ou Medical Center-The Children's Ho - Rad CT - HOPD

Acute Care Hospital outpatient department · Oklahoma City, Oklahoma

See all 5 affiliations

Find Dr. Furqan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Muhammad Furqan is a medical oncologist in Oklahoma City, Oklahoma

Dr. Furqan practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Furqan's NPI, 1306090220, was assigned on November 5, 2008. Dr. Furqan holds Iowa license MD-41701.

NPI and contact details
Medicare PAC ID
3678796281
NPI enumeration date
November 5, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Muhammad Furqan practices at Ou Medical Center-the Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma

Dr. Furqan's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

  • Ou Medical Center-the Children's Ho - Rad CT - HOPD
    1200 Childrens Ave, Oklahoma City, OK 73104

Source: Dmand AI Affiliation Data

Dr. Muhammad Furqan is affiliated with 4 sites of care and 1 medical group

Dr. Furqan's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Furqan is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Furqan to 1 more hospital and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Furqan

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Muhammad Furqan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Furqan practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Ou Medical Center-The Children's Ho - Rad CT - HOPDAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Furqan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Muhammad Furqan is one of 10 medical oncologists in Oklahoma

Medical oncology is Dr. Furqan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Furqan is licensed in Iowa.

Specialties and state licenses

  • Medical oncology, IowaPrimaryLicense MD-41701 · taxonomy 207RX0202X

Medical oncologists near Dr. Furqan

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

10medical oncologists in Oklahoma
3medical oncologists in Oklahoma City

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Muhammad Furqan billed Medicare for 718 services in 2024

CMS data shows 718 Medicare services from Dr. Furqan across 3 procedure codes in 2024, all of them office visits, for 234 Medicare patients. Medicare paid $55,405 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024718
Medicare patients234
Paid by Medicare$55,405
Procedure codes3

Dr. Furqan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5652024: 71827%

Dr. Furqan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Furqan

Need commercial claims for Dr. Furqan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Furqan and other medical oncologists in Oklahoma.

Book a meeting

Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data

Dr. Muhammad Furqan treated 234 Medicare patients in 2024, average age 73

CMS counts 234 Medicare patients who saw Dr. Furqan in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have cancer, and 70% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Furqan's median patient age at 73, with 56% women.

Medicare patients, 2024234
Average age73
Average risk score2.55
Also on Medicaid6%

Dr. Furqan's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Furqan's Medicare patients by sex, 2024

  • Women13558%
  • Men9942%

Chronic conditions among Dr. Furqan's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol70%
  3. High blood pressure69%
  4. COPD52%
  5. Tobacco use35%
  6. Anxiety33%
  7. Arthritis29%
  8. Ischemic heart disease28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Furqan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women56%
  • Men44%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Muhammad Furqan wrote 1,267 Medicare Part D claims in 2024

In 2024, Dr. Furqan wrote 1,267 Medicare Part D claims for 173 patients. 79% of them were for generic drugs. CMS names the drug for 1,027 of them, across 25 drugs with 11 or more claims each, at $925,975 in total drug cost. In 2023, CMS named 822 claims across 27 drugs.

Part D claims, 20241,267
Drugs named by CMS25
Total drug cost$925,975
Part D patients173

Dr. Furqan's Part D claims by kind of drug, 2024

  • Generic998 claims79%
  • Brand-name269 claims21%

Dr. Furqan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Furqan's Part D claims, 2024

  • Opioids8%96 of 1,267 claims
  • Antibiotics3%35 of 1,267 claims
  • Antipsychotics, patients 65 and over10%122 of 1,267 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 8222024: 1,02725%

Drugs named by CMS: 25 in 2024, 27 in 2023.

See all prescribing by Dr. Furqan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Muhammad Furqan scored 80 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Furqan for performance year 2024, reported as part of a group. Dr. Furqan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Furqan's MIPS scores, performance year 2024

  • 80of 100Final score
  • 75.7of 100Quality
  • 78of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Furqan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Muhammad Furqan has 77 publications on record

Dmand AI links 77 papers to Dr. Furqan, published from 2013 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Lung Neoplasms, Antineoplastic Agents and Carcinoma, Non-Small-Cell Lung. Dr. Furqan has published most often in Transl Lung Cancer Res. Dr. Furqan's most frequent co-authors are Allan L. Klein, MD, Gerald H. Clamon, MD and Beni R. Verma, MD.

Papers77
Years published2013 to 2025

Dr. Furqan's papers by year, 2016 to 2025

Topics Dr. Furqan writes about most

  • Lung Neoplasms
  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Pericarditis
  • Antineoplastic Combined Chemotherapy Protocols
  • Immunotherapy
  • Cell Line, Tumor
  • Pericardial Effusion

Dr. Furqan's most frequent co-authors

Recent publications by Dr. Furqan

See all 77 publications and co-authors

See who Dr. Furqan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Furqan works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Muhammad Furqan has worked on 10 clinical trials

Dmand AI links Dr. Furqan to 10 clinical trials, 5 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.

Clinical trials with Dr. Furqan by phase

  1. NonePhase 1: no trials
  2. 4Phase 2: 4 trials
  3. 5Phase 3: 5 trials
  4. NonePhase 4: no trials

Conditions in Dr. Furqan's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic
  • Lung Neoplasms
  • Thoracic Neoplasms
  • Genomic Instability

Investigators on the most trials with Dr. Furqan

Recent clinical trials with Dr. Furqan

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Muhammad Furqan received $13,872 in industry payments from 2016 to 2025

CMS Open Payments shows 22 general payments to Dr. Furqan from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,820. It also lists 1 research payment totaling $190 in 2018.

General payments to Dr. Furqan by program year, 2016 to 2025

General payments to Dr. Furqan by kind, 2016 to 2025

$13.9Kin total
  • Consulting fees$10,73577%
  • Travel and lodging$2,82020%
  • Food and beverage$2262%
  • Education$911%

Companies that paid Dr. Furqan the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Furqan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Muhammad Furqan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Muhammad Furqan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Muhammad Furqan's NPI number?

Dr. Muhammad Furqan's NPI number is 1306090220. It was assigned on November 5, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Muhammad Furqan?

Dr. Muhammad Furqan is a medical oncologist in Oklahoma City, Oklahoma. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Muhammad Furqan practice?

Dr. Furqan practices at 1200 Childrens Ave, Oklahoma City, OK 73104. Dr. Furqan's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dmand AI also links Dr. Furqan to 1 hospital and 1 group practice or clinic.

What is Dr. Muhammad Furqan's medical license number?

Dr. Furqan holds Iowa license MD-41701.

Which hospitals is Dr. Muhammad Furqan affiliated with?

Dr. Furqan is affiliated with OU Health University of Oklahoma Medical Center. Dmand AI links Dr. Furqan to 1 more hospital.

What medical group is Dr. Muhammad Furqan part of?

Dr. Furqan is linked to OU Health.

Does Dr. Muhammad Furqan accept Medicare?

Yes. CMS data shows Dr. Furqan billed Medicare for 718 services in 2024, and Dr. Furqan accepts Medicare assignment.

What is Dr. Muhammad Furqan's MIPS score?

Dr. Furqan's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.

How many Medicare patients does Dr. Muhammad Furqan see?

CMS counts 234 Medicare patients who saw Dr. Furqan in 2024, with an average age of 73.

What services does Dr. Muhammad Furqan bill to Medicare?

In 2024, Dr. Furqan's most billed Medicare services were office visit, established patient (99214), office visit, new patient (99205) and office visit, established patient (99215).

Show 5 more questionsShow fewer questions

What drugs does Dr. Muhammad Furqan prescribe most?

In 2024 Medicare Part D data, Dr. Furqan's most prescribed drugs by claims were Olanzapine, Prochlorperazine Maleate and Ondansetron HCl.

Has Dr. Muhammad Furqan received payments from drug or device companies?

CMS Open Payments shows $13,872 in general payments to Dr. Furqan from 8 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Muhammad Furqan been practicing?

Dr. Furqan graduated from medical school in 2005, 21 years ago.

Does Dr. Muhammad Furqan do research?

Dmand AI links 77 publications to Dr. Furqan, published from 2013 to 2025. Dr. Furqan has worked on 10 clinical trials.

Who does Dr. Muhammad Furqan publish with?

Dr. Furqan's most frequent co-authors are Allan L. Klein, MD (15 shared papers), Gerald H. Clamon, MD (10 shared papers) and Beni R. Verma, MD (9 shared papers).

Selling to medical oncology practices?

See medical oncologists in Oklahoma by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)